The identification of distinct correlations in clinical characteristics and biomolecular features between ACPA– and ACPA+ RA motivated us to further investigate the differences in the abundance of individual plasma proteins between study groups. The gene discussed is PRTN3; the disease is rheumatoid arthritis.